South Korea Daewoong Pharma Eyes Phase II Trials Of Coronavirus Drug, Shares Jump

South Korean drugmaker Daewoong Pharma said on Thursday it had sought regulatory approval for Phase II trials of its antiparasite niclosamide drug to treat COVID19 patients, sending its shares up nearly 6%.

from Top Business News- News18.com https://ift.tt/37yA5Is

• Tweet
• Share
• Share
• Share
• Share